RecruitingPhase 1NCT06199479
Radiologic Pathologic Correlation of Imaging to Distinguish True Progression From Pseudoprogression in Brain Malignancies
Sponsor
M.D. Anderson Cancer Center
Enrollment
25 participants
Start Date
Jun 4, 2024
Study Type
INTERVENTIONAL
Conditions
Summary
To learn if advanced imaging methods can tell apart true progression (the disease has actually gotten worse) from pseudoprogression (the disease appears to have gotten worse, but it actually has not).
Eligibility
Min Age: 18 Years
Plain Language Summary
Simplified for easier understanding
This study compares what brain MRI scans show with what the tumor actually looks like under the microscope in adults with brain tumors (gliomas). This helps researchers understand how well MRI scans can distinguish between true tumor growth, treatment-related changes, and scar tissue.
**You may be eligible if...**
- You are over 18 years old
- You have had prior treatment for a brain tumor
- You have a new or suspicious finding on a brain scan that may require further diagnosis
- You are willing to attend all study visits and evaluations
**You may NOT be eligible if...**
- You are under 18 (pediatric brain tumors have a different profile and are excluded)
- You are unwilling or unable to complete required visits
Talk to your doctor to see if this trial is right for you.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
PROCEDUREMRI Scan
Performed by MRI Scan
PROCEDURECT Scan
Performed by CT Scan
PROCEDUREBiopsy
Standard of Care Biopsy
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06199479